Why Tenet Healthcare (THC) Stock Is Up Today

Tenet Healthcare (THC) is up 9.0% today. Here is some analysis on what might have caused this price movement.

Analysis: The move appears tied to a mix of improving sentiment rather than a single fresh company announcement. Investors may be reacting to a recent credit-rating upgrade, Tenet’s already strong 2026 operating results and guidance, and growing focus on its July 24 second-quarter report.

Details:

Tenet recently said it will report second-quarter 2026 results on July 24, which can draw buyers when investors expect another solid quarter.

In first-quarter 2026 results, the company posted strong earnings, raised or reaffirmed confidence in its operating outlook, and highlighted continued cash generation.

Earlier in 2026, Tenet outlined an agreement tied to Conifer and CommonSpirit that included sizable payments to Tenet over the next three years, reinforcing balance-sheet flexibility.

A recent credit-rating upgrade pointed to sustained deleveraging, EBITDA strength, debt reduction, and disciplined capital allocation, which could be supporting today’s rally.

Sources:

Tenet Healthcare, SEC, Investing.com

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$THC Insider Trading Activity

$THC insiders have traded $THC stock on the open market 13 times in the past 6 months. Of those trades, 0 have been purchases and 13 have been sales.

Here’s a breakdown of recent trading of $THC stock by insiders over the last 6 months:

THOMAS W ARNST (EVP, Chief Admin. Officer & GC) has made 0 purchases and 3 sales selling 32,000 shares for an estimated $7,527,737.
R. SCOTT RAMSEY (Principal Accounting Officer) has made 0 purchases and 3 sales selling 8,017 shares for an estimated $1,865,576.
PAOLA M ARBOUR (EVP, Chief Information Officer) sold 6,500 shares for an estimated $1,549,795
J ROBERT KERREY has made 0 purchases and 5 sales selling 5,638 shares for an estimated $983,920.
NADJA WEST sold 3,000 shares for an estimated $532,050

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

EARLY ACCESS

Receive THC Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$THC Hedge Fund Activity

We have seen 288 institutional investors add shares of $THC stock to their portfolio, and 339 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

WELLINGTON MANAGEMENT GROUP LLP added 1,209,118 shares (+106.5%) to their portfolio in Q1 2026, for an estimated $228,172,657
AQR CAPITAL MANAGEMENT LLC removed 813,951 shares (-36.1%) from their portfolio in Q1 2026, for an estimated $153,600,693
GLENVIEW CAPITAL MANAGEMENT, LLC removed 798,825 shares (-34.4%) from their portfolio in Q1 2026, for an estimated $150,746,265
NUVEEN, LLC removed 675,646 shares (-58.5%) from their portfolio in Q1 2026, for an estimated $127,501,156
KHROM CAPITAL MANAGEMENT LLC removed 504,279 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $95,162,490
QUBE RESEARCH & TECHNOLOGIES LTD added 499,399 shares (+324.4%) to their portfolio in Q1 2026, for an estimated $94,241,585
CAPITAL WORLD INVESTORS added 491,957 shares (+inf%) to their portfolio in Q1 2026, for an estimated $92,837,205

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$THC Government Contracts

We have seen $270,000 of award payments to $THC over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

STERILE PROCESSING SERVICES: $135,000

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.

$THC Congressional Stock Trading

Members of Congress have traded $THC stock 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $THC stock by members of Congress over the last 6 months:

REPRESENTATIVE JONATHAN L. JACKSON has traded it 3 times. They made 0 purchases and 3 sales worth up to $80,000 on 04/20, 04/15, 02/11.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$THC Analyst Ratings

Wall Street analysts have issued reports on $THC in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Wells Fargo issued a "Overweight" rating on 01/07/2026

To track analyst ratings and price targets for $THC, check out Quiver Quantitative's $THC forecast page.

$THC Price Targets

Multiple analysts have issued price targets for $THC recently. We have seen 13 analysts offer price targets for $THC in the last 6 months, with a median target of $252.0.

Here are some recent targets:

Ryan Langston from TD Cowen set a target price of $233.0 on 06/22/2026
Michael Ha from Baird set a target price of $210.0 on 05/05/2026
Andrew Mok from Barclays set a target price of $238.0 on 05/05/2026
Raj Kumar from Stephens & Co. set a target price of $260.0 on 05/04/2026
Stephen Baxter from Wells Fargo set a target price of $213.0 on 05/01/2026
Matthew Gillmor from Keybanc set a target price of $225.0 on 05/01/2026
Jason Cassorla from Guggenheim set a target price of $252.0 on 05/01/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.